An AICD-based functional screen to identify APP metabolism regulators
Can Zhang, Preeti J. Khandelwal, Ranjita Chakraborty, Trinna L. Cuellar, Srikant Sarangi, Shyam A. Patel, Christopher P. Cosentino, Michael O'Connor, Jeremy C. Lee, Rudolph E. Tanzi, …
Background: A central event in Alzheimer's disease (AD) is the regulated intramembraneous proteolysis of the beta-amyloid precursor protein (APP), to generate the beta-amyloid (A beta) peptide and the APP intracellular domain (AICD). A beta is the major component of amyloid plaques and AICD displays transcriptional activation properties. We have taken advantage of AICD transactivation properties to develop a genetic screen to identify regulators of APP metabolism. This screen relies on an APP-Gal4 fusion protein, which upon normal proteolysis, produces AICD-Gal4. Production of AICD-Gal4 induces Gal4-UAS driven luciferase expression. Therefore, when regulators of APP metabolism are modulated, luciferase expression is altered.
Results: To validate this experimental approach we modulated alpha-, beta-, and gamma-secretase levels and activities. Changes in AICD-Gal4 levels as measured by Western blot analysis were strongly and significantly correlated to the observed changes in AICD-Gal4 mediated luciferase activity. To determine if a known regulator of APP trafficking/maturation and Presenilin1 endoproteolysis could be detected using the AICD-Gal4 mediated luciferase assay, we knocked-down Ubiquilin 1 and observed decreased luciferase activity. We confirmed that Ubiquilin 1 modulated AICD-Gal4 levels by Western blot analysis and also observed that Ubiquilin 1 modulated total APP levels, the ratio of mature to immature APP, as well as PS1 endoproteolysis.
Conclusion: Taken together, we have shown that this screen can identify known APP metabolism regulators that control proteolysis, intracellular trafficking, maturation and levels of APP and its proteolytic products. We demonstrate for the first time that Ubiquilin 1 regulates APP metabolism in the human neuroblastoma cell line, SH-SY5Y.
An AICD-based functional screen to identify APP metabolism regulators
Creators
Can Zhang - Drexel University
Preeti J. Khandelwal - Drexel University
Ranjita Chakraborty - Drexel University
Trinna L. Cuellar - Drexel University
Srikant Sarangi - Drexel University
Shyam A. Patel - Drexel University
Christopher P. Cosentino - Drexel University
Michael O'Connor - Drexel University
Jeremy C. Lee - Drexel University
Rudolph E. Tanzi - Massachusetts General Hospital
Aleister J. Saunders - Drexel University
Publication Details
Molecular neurodegeneration, v 2(1), 15
Publisher
Springer Nature
Number of pages
19
Grant note
R01NS057295 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
Drexel University
NINDS (AJS); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
Commonwealth of PA
Resource Type
Journal article
Language
English
Academic Unit
Biodiversity, Earth, and Environmental Science (BEES); Biology
Web of Science ID
WOS:000206907200015
Scopus ID
2-s2.0-36048978614
Other Identifier
991019169410704721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: